216 related articles for article (PubMed ID: 1905005)
1. Human Harvey-ras is biochemically different from Kirsten- or N-ras.
Carbone A; Gusella GL; Radzioch D; Varesio L
Oncogene; 1991 May; 6(5):731-7. PubMed ID: 1905005
[TBL] [Abstract][Full Text] [Related]
2. [The c-fos proto-oncogene promotor is not regulated by serum, epidermal growth factor, and phorbol ester in embryonal fibroblasts transformed by E1Aad5+cHa-ras-oncogenes].
Pospelova TV; Medvedev AV; Kisliakova TV; Svetlikova SB; Pospelov VA
Mol Biol (Mosk); 1991; 25(1):105-15. PubMed ID: 1716733
[TBL] [Abstract][Full Text] [Related]
3. Phorbol ester-mediated inhibition of growth and regulation of proto-oncogene expression in the human T cell leukemia line JURKAT.
Makover D; Cuddy M; Yum S; Bradley K; Alpers J; Sukhatme V; Reed JC
Oncogene; 1991 Mar; 6(3):455-60. PubMed ID: 2011401
[TBL] [Abstract][Full Text] [Related]
4. Constitutively activated neu oncoprotein tyrosine kinase interferes with growth factor-induced signals for gene activation.
Lehtola L; Sistonen L; Koskinen P; Lehväslaiho H; Di Renzo MF; Comoglio PM; Alitalo K
J Cell Biochem; 1991 Jan; 45(1):69-81. PubMed ID: 1706346
[TBL] [Abstract][Full Text] [Related]
5. 2-Aminopurine abolishes EGF- and TPA-stimulated pp33 phosphorylation and c-fos induction without affecting the activation of protein kinase C.
Mahadevan LC; Wills AJ; Hirst EA; Rathjen PD; Heath JK
Oncogene; 1990 Mar; 5(3):327-35. PubMed ID: 2107492
[TBL] [Abstract][Full Text] [Related]
6. Differential induction of c-fos and c-jun proto-oncogenes and AP-1 activity by tumor promoter 12-O-tetradecanoyl phorbol 13-acetate in cells at different stages of tumor promotion in vitro.
Wu WS; Lin JK; Wu FY
Oncogene; 1992 Nov; 7(11):2287-94. PubMed ID: 1437150
[TBL] [Abstract][Full Text] [Related]
7. H-ras and raf-1 cooperate in transformation of NIH3T3 fibroblasts.
Cuadrado A; Bruder JT; Heidaran MA; App H; Rapp UR; Aaronson SA
Oncogene; 1993 Sep; 8(9):2443-8. PubMed ID: 8361757
[TBL] [Abstract][Full Text] [Related]
8. Changes in c-myc and c-fos expression in a human tumor cell line following exposure to bifunctional alkylating agents.
Futscher BW; Erickson LC
Cancer Res; 1990 Jan; 50(1):62-6. PubMed ID: 2104539
[TBL] [Abstract][Full Text] [Related]
9. Raf revertant cells resist transformation by non-nuclear oncogenes and are deficient in the induction of early response genes by TPA and serum.
Kolch W; Heidecker G; Troppmair J; Yanagihara K; Bassin RH; Rapp UR
Oncogene; 1993 Feb; 8(2):361-70. PubMed ID: 8426742
[TBL] [Abstract][Full Text] [Related]
10. Induction of c-fos and c-jun mRNA expression by basic fibroblast growth factor in cultured rat Müller cells.
Cao W; Li F; Steinberg RH; LaVail MM
Invest Ophthalmol Vis Sci; 1998 Mar; 39(3):565-73. PubMed ID: 9501868
[TBL] [Abstract][Full Text] [Related]
11. Differential regulation and expression of jun, c-fos and c-myc proto-oncogenes during mouse liver regeneration and after inhibition of protein synthesis.
Morello D; Lavenu A; Babinet C
Oncogene; 1990 Oct; 5(10):1511-9. PubMed ID: 2123531
[TBL] [Abstract][Full Text] [Related]
12. Influence of exogenous ras and p53 on P-glycoprotein function in immortalized rodent fibroblasts.
Kopnin BP; Stromskaya TP; Kondratov RV; Ossovskaya VS; Pugacheva EN; Rybalkina EY; Khokhlova OA; Chumakov PM
Oncol Res; 1995; 7(6):299-306. PubMed ID: 8527864
[TBL] [Abstract][Full Text] [Related]
13. IL-1 signal transduction pathways. I. Two functional IL-1 receptors are expressed in T cells.
Muñoz E; Zubiaga AM; Sims JE; Huber BT
J Immunol; 1991 Jan; 146(1):136-43. PubMed ID: 1845804
[TBL] [Abstract][Full Text] [Related]
14. Forskolin and a tumor promoter are able to induce c-fos and c-myc expression in normal, but not in a v-ras-transformed rat thyroid cell line.
Colletta G; Cirafici AM; Consiglio E; Vecchio G
Oncogene Res; 1987; 1(4):459-66. PubMed ID: 3329719
[TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor-alpha expression is enhanced in human mammary epithelial cells transformed by an activated c-Ha-ras protooncogene but not by the c-neu protooncogene, and overexpression of the transforming growth factor-alpha complementary DNA leads to transformation.
Ciardiello F; McGeady ML; Kim N; Basolo F; Hynes N; Langton BC; Yokozaki H; Saeki T; Elliott JW; Masui H
Cell Growth Differ; 1990 Sep; 1(9):407-20. PubMed ID: 1981145
[TBL] [Abstract][Full Text] [Related]
16. Correlation between successful heterotransplantation of lung tumors in nude mice, poor prognosis of patients and expression of Fos, Jun, ErbB1, and Ras.
Volm M; Mattern J
Anticancer Res; 1993; 13(6A):2021-5. PubMed ID: 8297109
[TBL] [Abstract][Full Text] [Related]
17. Serum growth factors up-regulate H-ras, K-ras, and N-ras proto-oncogenes in fibroblasts.
Quincoces AF; León J
Cell Growth Differ; 1995 Mar; 6(3):271-9. PubMed ID: 7794795
[TBL] [Abstract][Full Text] [Related]
18. Modulation of c-myc, c-myb, c-fos, c-sis and c-fms proto-oncogene expression and of CSF-1 transcripts and protein by phorbol diester in human malignant histiocytosis DEL cell line with 5q 35 break point.
Gogusev J; Barbey S; Nezelof C
Anticancer Res; 1993; 13(4):1043-7. PubMed ID: 8352523
[TBL] [Abstract][Full Text] [Related]
19. Tumor-promoting phorbol ester and activated Ha-ras synergistically reduce the interleukin 3 requirement in a mast cell line.
Imber R; Fabbro D
Cancer Res; 1991 Jan; 51(2):632-8. PubMed ID: 1985780
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of c-fos gene transcription in cells transformed by E1A and cHa-ras oncogenes: a role of sustained activation of MAP/ERK kinase cascade and of inactive chromatin structure at c-fos promoter.
Kukushkin AN; Abramova MV; Svetlikova SB; Darieva ZA; Pospelova TV; Pospelov VA
Oncogene; 2002 Jan; 21(5):719-30. PubMed ID: 11850800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
